Scinai Immunotherapeutics
SCNI----
Scinai Immunotherapeutics (SCNI)
Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the researc...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Scinai Immunotherapeutics Analyst Rating
View moreForecast & Rating
Jan 3, 2024Price forecast
$7000.001296196.30%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Movers ·
Scinai Immunotherapeutics tumbles 8%
- Market Movers ·
Scinai Immunotherapeutics falls 11% to record low
- benzinga_article ·
12 Health Care Stocks Moving In Thursday's After-Market Session
- Tip Ranks ·
Scinai Immunotherapeutics Extends Cash Runway on New CDMO Deal and October Financing
- TradingView ·
Scinai Immunotherapeutics Ltd. (SCNI) Secures $5.1M CDMO Work, Runway to Late 2027
- StockTitan ·
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing | SCNI Stock News
